Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization (Info-Vac)

Université de Reims Champagne-Ardenne

Status: Unknown

Conditions: Vaccination

Treatments: Other: Data collection: DTPolio vaccine delivery

Study type: Observational

Funder types: Other

Identifiers

NCT04869735

2021-003-Info-Vac

Details and patient eligibility

About

The aim of vaccination is to protect the patient against disease by stimulating his immune system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria, tetanus and polio.

In France, the vaccination schedule sets the vaccination recommendations applicable to people according to their age. In this schedule, a booster of DTPolio at the age of 25 is recommended.

The vaccination coverage for patients over 16 years of age is insufficient in France.

Full description

The aim of the study is to evaluate impact of information about booster vaccination against DTPolio at 25 years on this booster vaccination's realization.

Enrollment: 2,125 estimated patients

Sex: All

Ages: 25 to 25 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• aged 25 years old in 2020
• without delivery of DTPolio vaccine in 2019 or 2020

Exclusion criteria

• None

Trial design

2,125 participants in 2 patient groups

With information about booster vaccination

Description:

Adults aged 25 years in 2020 without delivery of DTPolio vaccine in 2019 or 2020, to whom information concerning this vaccination is given

Treatment:

Other: Data collection: DTPolio vaccine delivery

Without information about booster vaccination

Description:

Adults aged 25 years in 2020 without delivery of DTPolio vaccine in 2019 or 2020, to whom information concerning this vaccination is not given.

Treatment:

Other: Data collection: DTPolio vaccine delivery